Udayavni Special

Organ transplant recipients vulnerable to COVID-19 even after vaccination, says study


PTI, May 10, 2021, 2:07 PM IST

New Delhi: Although two doses of a COVID-19 vaccine confer some protection for people who have received solid organ transplants, it’s still not enough to enable them to dispense with masks, physical distancing and other safety measures, according to a study.

This is a follow-up study to an earlier one in which the researchers reported that only 17 per cent of the participating transplant recipients produced sufficient antibodies after just one dose of a two-dose COVID-19 vaccine regimen.

”While there was an increase in those with detectable antibodies after the second shot, the number of transplant recipients in our second study whose antibody levels reached high enough levels to ward off infection was still well below than in people with healthy immune systems,” said study lead author Brian Boyarsky from the Johns Hopkins University School of Medicine in the US.

”Based on our findings, we recommend that transplant recipients and other immunocompromised patients continue to practice strict COVID-19 safety precautions, even after vaccination,” Boyarsky said.

The researchers noted that people who receive solid organ transplants, such as hearts, lungs and kidneys, often must take drugs to suppress their immune systems and prevent rejection.

Such regimens may interfere with a transplant recipient’s ability to make antibodies to foreign substances, including the protective ones produced in response to vaccines, they said.

The latest study, published in the Journal of the American Medical Association (JAMA), evaluated this immunogenic response following the second dose of either of the two mRNA vaccines – made by Moderna and Pfizer-BioNTech – for 658 transplant recipients, none of whom had a prior diagnosis of COVID-19.

The participants completed their two-dose regimen between December 16, 2020, and March 13, 2021.

The researchers found that only 98 of the 658 study participants – 15 per cent – had detectable antibodies to SARS-CoV-2 at 21 days after the first vaccine dose.

This was comparable to the 17 per cent reported in the March study looking at the immune response after only one vaccine dose.

At 29 days following the second dose, the number of participants with detectable antibodies rose to 357 out of 658 – 54 per cent, the researchers said.

After both vaccine doses were administered, 301 out of 658 participants – 46 per cent – had no detectable antibody at all while 259 – 39 per cent – only produced antibodies after the second shot, they said.

The researchers also found that among the participants, the most likely to develop an antibody response were younger, did not take immunosuppressive regimens including anti-metabolite drugs and received the Moderna vaccine.

These were similar to the associations seen in the March single-dose study, they said.

”Given these observations, transplant recipients should not assume that two vaccine doses guarantee sufficient immunity against SARS-CoV-2 any more than it did after just one dose,” said study co-author Dorry Segev, from the Johns Hopkins University School of Medicine.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

VivaTech Summit: Modi calls for ‘repair and prepare’ as India emerges from pandemic

Chirag Paswan writes to LS Speaker against notification in favour of Paras as LJP leader

Most drugs for treating adult Covid patients not recommended for kids: Govt guidelines

HC sets aside arbitration award that required BCCI to pay Rs 4,800 crore to DCHL

Sonu Sood projected as messiahs without verifying if Covid drugs were legally supplied: Bombay HC

Social media posts twisted facts, final product doesn’t have newborn calf serum: Centre on Covaxin

Bigg Boss Kannada season 8 version 2.0 to resume this month



Related Articles More

Exposure to common cold virus may protect from COVID-19: Study

A fifth of asymptomatic covid patients develop ‘Long Covid’: study

Abbott launches medical device to treat congenital heart defects in premature infants

Two doses mostly prevent hospitalisation with Delta variant: UK Body

Over half of adults unvaccinated for COVID-19 fear needles – here’s what’s proven to help

MUST WATCH

Suresh Shetty Gulme | Success Story of Modern Cow Dairy Farming | Kannada

Complete Guide on Mango Farming | Harvesting Techniques

Rains in Malenadu continue, life becomes chaotic

Harsha Kamath Karkala | Correct Way of Consuming Kashaya | Home Remedy

COVID patient threatened to drink poison if sent to care centre

Latest Additions

Delhi Police moves SC against HC order granting bail to 3 student activists in riots cases

VivaTech Summit: Modi calls for ‘repair and prepare’ as India emerges from pandemic

Cristiano Ronaldo’s one gesture wipes $4 bn off Coca cola’s market value

3 CoEs to use Israeli tech in horticulture opened in Karnataka

Chirag Paswan writes to LS Speaker against notification in favour of Paras as LJP leader

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.